Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.
Luxton, H J
AffiliationUro-Oncology Research Group, Cambridge CB2 0RE, UK.
MetadataShow full item record
AbstractObjective:We have previously identified peroxiredoxin-3 (PRDX-3) as a cell-surface protein that is androgen regulated in the LNCaP prostate cancer (PCa) cell line. PRDX-3 is a member of the peroxiredoxin family that are responsible for neutralising reactive oxygen species.Experimental design:PRDX-3 expression was examined in tissue from 32 patients using immunohistochemistry. Subcellular distribution was determined using confocal microscopy. PRDX-3 expression was determined in antiandrogen-resistant cell lines by western blotting and quantitative RT-PCR. The pathways of PRDX-3 overexpression and knockdown on apoptosis and response to oxidative stress were investigated using protein arrays.Results:PRDX-3 is upregulated in a number of endocrine-regulated tumours; in particular in PCa and prostatic intraepithelial neoplasia. Although the majority of PRDX-3 is localised to the mitochondria, we have confirmed that PRDX-3 at the cell membrane is androgen regulated. In antiandrogen-resistant LNCaP cell lines, PRDX-3 is upregulated at the protein but not RNA level. Resistant cells also possess an upregulation of the tricarboxylic acid (TCA) pathway and resistance to H2O2-induced apoptosis through a failure to activate pro-apoptotic pathways. Knockdown of PRDX-3 restored H2O2 sensitivity.Conclusion:Our results suggest that PRDX-3 has an essential role in regulating oxidation-induced apoptosis in antiandrogen-resistant cells. PRDX-3 may have potential as a therapeutic target in castrate-independent PCa.
CitationPeroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress. 2013, 109 (4):983-93 Br J Cancer
JournalBritish Journal of Cancer
- Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
- Authors: Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, Jia Z, Lilly MB, De León M, Casiano CA
- Issue date: 2011 May 15
- Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.
- Authors: Lu W, Fu Z, Wang H, Feng J, Wei J, Guo J
- Issue date: 2014 Feb
- Repression of the mitochondrial peroxiredoxin antioxidant system does not shorten life span but causes reduced fitness in Caenorhabditis elegans.
- Authors: Ranjan M, Gruber J, Ng LF, Halliwell B
- Issue date: 2013 Oct
- Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
- Authors: Das S, Roth CP, Wasson LM, Vishwanatha JK
- Issue date: 2007 Oct 1
- The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
- Authors: Correa RG, Krajewska M, Ware CF, Gerlic M, Reed JC
- Issue date: 2014 Mar 30